New quarterly report expected Apr 22, 2026. Report will refresh after results.
R
Rollins, Inc.
ROL · Consumer Cyclical
Q4 FY2025
Earning ended Dec 31, 2025Report generated Mar 10, 2026
Rollins Has the Moat and the Machine — But Not the Margin of Safety
Most investors own Rollins as a quality compounder and stop there — the second-level question they're skipping is whether the M&A integration playbook, not the Orkin brand, is the actual irreplaceable asset, and what happens to the growth story if private equity's insatiable appetite for service businesses quietly exhausts the supply of small family operators willing to sell at rational prices. The ancillary cross-sell opportunity, sitting at under four percent penetration across specialty brands, is the overlooked growth lever hiding inside a business most people think they already fully understand.
Flowly Score
Apr 16 Close
+1%$54.49
Fair Value
$55.00
59
Averageat $54.49
Business Strength8/10
A route-density subscription machine with genuine multi-layered moats — scale economies, switching costs, century-old brand trust, and a serial M&A integration capability that functions as a proprietary process others cannot replicate quickly. The sustained elite ROIC across five years in a no-patent, no-platform business is the honest scorecard of a real economic advantage.
Financial Resilience8/10
Operating cash flow running structurally ahead of net income, near-zero capex intensity, and full-year free cash flow growing double-digits despite Q4 weather headwinds — this business generates cash with the reliability of a toll road. The debt jump from the Sela acquisition looks alarming in isolation but dissolves at a sub-one-times EBITDA leverage ratio, leaving the balance sheet essentially unlevered for the next deal.
Growth & Trajectory7/10
Organic growth in the high single digits, compounding through price, density improvements, and a fragmented acquisition pipeline — consistent, not spectacular, but with genuine structural acceleration from climate-driven pest persistence and an ancillary cross-sell opportunity sitting at under four percent penetration in most brands. The trajectory is quietly improving in the dimensions that matter most: new technician retention, fleet cost normalization, and CRM-enabled cross-brand referrals just beginning to monetize.
Valuation4/10at $57.57
At a price meaningfully above the neutral DCF and with a P/E in the mid-fifties that has been consistent for half a decade, the market has already priced in the quality and then left no margin for the unexpected — a weather quarter, a tight labor market, or a stumble in the M&A pipeline. The gap between an earnings yield below two percent and the actual reinvestment opportunities available to the business is the most precise way to say: you are paying for perfection.
Risk6/10
The underlying business is genuinely resilient — demand doesn't soften in recessions, customers don't cancel in downturns, and there are no binary regulatory or technological cliff edges visible in the near term. What keeps this from a higher score is the convergence of three quiet risks: lab-cost inflation that the Q4 margin data has already hinted at, private equity competition exhausting the acquisition pipeline, and an IoT monitoring wave that could shift commercial accounts toward remote detection over time.
Rollins is the rare business where the quality case is essentially closed — recurring subscription demand, route density economics that widen with scale, a century-old brand in a trust-sensitive category, and a serial acquisition machine that earns elite returns on deployed capital without destroying value in the integration. The problem isn't the business. The problem is that the market has spent half a decade figuring out exactly what Rollins is worth and pricing it accordingly — which means every dollar invested today is paying full freight for a future that must deliver at the high end of plausible outcomes with no allowance for friction. The business is actually accelerating quietly in ways the headline multiple obscures: new technician retention improved meaningfully in 2025, fleet costs normalize in 2026, and the ancillary segment — wildlife removal, mosquito control, bed bugs — is growing at twice the rate of core pest control with penetration so low in acquired brands that the organic cross-sell runway alone could add years of above-trend growth without a single new acquisition. The Sela integration exceeded expectations and the M&A pipeline looks full. If the company executes its stated 2026 targets, the multiple compresses through earnings growth rather than price appreciation — a perfectly fine outcome, but not one that rewards patience generously. The single biggest risk is not technology disruption or a recession — it is that the human technician is both the product and the cost, and every margin tailwind management has engineered can be erased if field labor wages permanently reset higher. The Q4 gross margin compression was a preview: when volume softens even briefly, this business absorbs it through staffing levels held high to protect retention, not cut to protect margins. That is the right long-term choice, but it means the P&L is more exposed to labor economics than the clean ROIC history suggests, and the current multiple offers nothing to absorb that reality if it persists.